Advanced Practice Providers (APP) Oncology Summit is organized by Horizon CME and will be held from Jul 12 - 13, 2019 at Philadelphia Airport Marriott, Philadelphia, Pennsylvania, United States of America.
Nurse Practitioners, Physician Assistants, Clinical Nurse Specialists, Oncology Pharmacists, and other healthcare professionals involved in the management of oncology patients.
This educational activity will be submitted to the American Association of Nurse Practitioners for approval of up to 12.0 contact hours of accredited education (hours pharmacology TBD).
This program is not yet approved for CME credit. Conference organizers plan to request 12.0 AAPA Category 1 CME credits from the Physician Assistant Review Panel. A total number of approved credits yet to be determined.
This activity has been submitted to the Washington State Pharmacy Association for approval to award up to 12.0 credit hours.
The Nurse Practitioner Healthcare Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Upon completion, NPs and RNs will be awarded up to 12 contact hours.
Conference Description :
The goal of the summit is to foster collaboration, share best practices and provide a forum for peer-to-peer interaction among Advanced Practice Providers (APP) in clinical practice who are actively engaged in the care of oncology patients. This summit will provide APP learners a broad overview of the latest developments and important current concepts in the multidisciplinary treatment of oncology patients. Additionally, the summit offers an intimate learning environment to facilitate interaction between learners and faculty so that clinicians can discuss practical patient management issues and then apply their learning once they return to practice.
Conference Objectives are :
• Assess evidence-based recommendations for the treatment of various hematologic and non-hematologic malignancies.
• Outline the requirements for implementing an institutional survivorship care plan.
• Review the tenets of genomic testing and how results may impact selection of cancer therapy.
• Anticipate potential adverse reactions associated with cancer treatment regimens or palliative drug therapies and employ prevention and mitigation strategies to reduce morbidity in cancer patients.
• Interpret imaging study results and communicate appropriate pre-imaging instructions to prepare patients prior to testing.
• Outline medication management strategies for individuals receiving oral anticancer agents.
Additional details will be posted as soon as they are available.
|Contact No. :||(503) 659-5558
|Registration Type||End Date||Price|
|Early Fee||12 Apr,2019||USD 40.00|
|Super Saver Fee||11 Jun,2019||USD 55.00|
|Advanced Fee||27 Jun,2019||USD 70.00|
|Last Chance Fee||11 Jul,2019||USD 85.00|
|Onsite Fee||13 Jul,2019||USD 125.00|
|Student Registration Fee||11 Jul,2019||USD 35.00|